Management Team
Ben Bobo, Co-Founder & CEO
Brandon Repko, MD, Co-Founder & Chief Scientific Officer
Hieu Le, Vice President, R&D
28+ years building medical device companies; 2 exits; 12 issued patents.
Ben Bobo is Co-Founder, CEO and Director of Retriever Medical, developer of the ClotHound thrombectomy platform for DVT and PE. He has spent 28+ years building, financing and commercializing medical devices, and has raised more than $48M over his career.
Ben got his
28+ years building medical device companies; 2 exits; 12 issued patents.
Ben Bobo is Co-Founder, CEO and Director of Retriever Medical, developer of the ClotHound thrombectomy platform for DVT and PE. He has spent 28+ years building, financing and commercializing medical devices, and has raised more than $48M over his career.
Ben got his start at Edwards Lifesciences in Edwards Critical Care, then held commercial and business development roles at CardioThoracic Systems (acquired by Guidant), Guidant and CardioVention. He co-founded InnerSpace Neuro Solutions and led it as CEO through FDA 510(k) clearance and commercial launch (assets acquired by IRRAS), and later founded Cerenetex. He is an inventor on 12 issued U.S. patents and holds a BS in Economics from the University of Utah and an MBA from the University of Phoenix.
Hieu Le, Vice President, R&D
Brandon Repko, MD, Co-Founder & Chief Scientific Officer
Hieu Le, Vice President, R&D
20+ years in device R&D; leads ClotHound design, testing and quality systems.
Hieu Le is Vice President of Research and Development at Retriever Medical. He brings 20+ years of engineering and product-development leadership in high-tech and medical device companies and has designed and developed multiple interventional device platforms.
20+ years in device R&D; leads ClotHound design, testing and quality systems.
Hieu Le is Vice President of Research and Development at Retriever Medical. He brings 20+ years of engineering and product-development leadership in high-tech and medical device companies and has designed and developed multiple interventional device platforms. At Retriever, he leads the design and testing of ClotHound, including the 2022 animal studies, and the quality system that supports FDA submissions. He co-authored the company’s three peer-reviewed papers and holds a BS in Aerospace Engineering and Mechanics from the University of Minnesota.
Brandon Repko, MD, Co-Founder & Chief Scientific Officer
Brandon Repko, MD, Co-Founder & Chief Scientific Officer
Brandon Repko, MD, Co-Founder & Chief Scientific Officer
Board-certified interventional radiologist; 20+ years treating blood vessels from the inside.
Brandon Repko, MD, is Co-Founder and Chief Scientific Officer of Retriever Medical. He is a board-certified radiologist with 20+ years in practice, specializing in vascular and interventional radiology and interventional neuroradiology: treating
Board-certified interventional radiologist; 20+ years treating blood vessels from the inside.
Brandon Repko, MD, is Co-Founder and Chief Scientific Officer of Retriever Medical. He is a board-certified radiologist with 20+ years in practice, specializing in vascular and interventional radiology and interventional neuroradiology: treating blood vessels from the inside with catheters. His hands-on clot-removal experience shapes ClotHound’s design and clinical strategy. He co-authored Retriever’s three peer-reviewed papers and earned his MD at Sidney Kimmel Medical College at Thomas Jefferson University.